|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
1994-6-17
|
|
pubmed:abstractText |
Goserelin is a gonadotrophin-releasing hormone (GnRH) analogue that induces the suppression of gonadal steroidogenesis, and it could therefore be a medical alternative to irreversible surgical castration. We report the clinical and endocrine results from 40 goserelin-treated premenopausal patients with advanced breast cancer.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0300-8916
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
28
|
|
pubmed:volume |
80
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
28-32
|
|
pubmed:dateRevised |
2008-12-12
|
|
pubmed:meshHeading |
pubmed-meshheading:8191594-Adult,
pubmed-meshheading:8191594-Breast Neoplasms,
pubmed-meshheading:8191594-Delayed-Action Preparations,
pubmed-meshheading:8191594-Estrogens,
pubmed-meshheading:8191594-Female,
pubmed-meshheading:8191594-Gonadotropins, Pituitary,
pubmed-meshheading:8191594-Goserelin,
pubmed-meshheading:8191594-Humans,
pubmed-meshheading:8191594-Middle Aged,
pubmed-meshheading:8191594-Ovary,
pubmed-meshheading:8191594-Premenopause,
pubmed-meshheading:8191594-Progesterone,
pubmed-meshheading:8191594-Survival Analysis,
pubmed-meshheading:8191594-Treatment Outcome
|
|
pubmed:year |
1994
|
|
pubmed:articleTitle |
Ovarian function suppression with the gonadotrophin-releasing hormone (GnRH) analogue goserelin in premenopausal advanced breast cancer.
|
|
pubmed:affiliation |
Division of Medical Oncology B, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy.
|
|
pubmed:publicationType |
Journal Article
|
